Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Seres Therapeutics (1S90.STU) Q2 2026 Earnings
1S90.STU
5
May
Confirmed
Q2 2026
-1.78
-1.72
-1.66
-1.6
Details
Expected EPS
-1.6043732
Actual EPS
-1.7750512
Surprise EPS
-0.17
Surprise Percent
+10.64%
Description
Seres Therapeutics (1S90.STU) has reported earnings of -1.7750512 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login